NOVAST Laboratories, Limited (SHE:301569)

NOVAST Laboratories Revenue

NOVAST Laboratories had revenue of 255.12M CNY in the quarter ending September 30, 2026, with 12.22% growth. This brings the company's total for the last twelve months to 1.01B. In the year 2025, NOVAST Laboratories had annual revenue of 895.47M with 3.38% growth. That makes NOVAST Laboratories the 19,567th largest company in the world by revenue and 3,585th in China.

• Revenue (ttm): 1.01B
• Revenue Growth: +3.38%
• P/S Ratio: 16.09
• Revenue / Employee: n/a
• Employees: 709
• Market Cap: 16.24B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Sales of Preparations 890.90M 99.5%
• R&D and Other Services 4.57M 0.5%

By Geography

Chart

• USA 565.48M 63.1%
• China 329.99M 36.9%

Fiscal year ended Dec 31, 2025 See the full NOVAST Laboratories breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	895.47M	29.25M	3.38%
Dec 31, 2024	866.22M	165.79M	23.67%
Dec 31, 2023	700.43M	150.36M	27.33%
Dec 31, 2022	550.07M	-96.31M	-14.90%
Dec 31, 2021	646.38M	81.04M	14.33%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error